In prostate cancer, reliable markers of disease status are important ... which previously evaluated whether a circulating tumor cell (CTC) cutoff of ≥5 cells per 7.5 ml predicted survival ...

The use of biomarkers in screening and optimization of the diagnostic strategy may avoid unnecessary biopsies and improve the prostate biopsy performance. Screening for prostate cancer (Pca) may ...

Two newly identified disease-causing genes, known as Bzw2 and Eif5a2, have been implicated in early prostate cancer ...

yet its role in the solid tumor spectrum has not been validated. A report into recurrent prostate cancer by Figg et al. 1 shows that thalidomide can reduce time to PSA progression in patients ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL ...

As is well known for other tumor markers such as CA 19-9, one can also detect elevated levels in benign diseases of the pancreas. In conclusion, pancreatic cancer Tumor M2-PK and CA 19-9 cannot be ...

"The current study exploits metabolic vulnerabilities unique to prostate cancer to starve it for essential nutrients and kill these tumor cells," Staschke said. This research was carried out by ...

The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

AI-driven MRI analysis offers new insights into prostate cancer prognosis, accurately predicting metastasis risk and ...